Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

75%

6 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 4

4(66.7%)

Phase 3

2(33.3%)

6Total

Phase 4(4)

Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT02539082Phase 4Unknown

the Safety and Efficacy of Collagen Injection in Patients With Plantar Fasciitis

Role: lead

NCT02539030Phase 4Unknown

Comparison of Efficacy and Safety of Microfracture and Modified Microfracture

Role: lead

NCT02524509Unknown

the Safety and Efficacy Evaluation of Chondron Compared With Mircrofracture of Knee

Role: lead

NCT02519881Phase 4Unknown

the Efficacy and Safety of a Modified Microfracture Using Collagen Compared to Those of a Simple Microfracture in Ankle

Role: lead

NCT02466048Phase 4Unknown

Efficacy and Safety of SurgiFill™ on Spinal Fusion

Role: lead

NCT01050816Phase 3Completed

Effects of CHONDRON (Autologous Chondrocytes) With Ankle Cartilage Defect

Role: lead

NCT01060943Phase 3Completed

An Efficacy and Safety Study of TheraFill® Versus KOKEN for 3 Months on Nasolabial Folds

Role: lead

NCT01056900Completed

Observation of the Result After Chondron (Autologous Chondrocytes) Treatment

Role: lead

All 8 trials loaded